查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲肺癌篩檢市場預測至 2030 年 - 區域分析 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）
市場調查報告書
商品編碼
1402532

南美洲和中美洲肺癌篩檢市場預測至 2030 年 - 區域分析 - 按癌症類型、技術、年齡層（50 歲及以上和 50 歲以下）和最終用戶（醫院、診斷中心等）

South & Central America Lung Cancer Screening Market Forecast to 2030 - Regional Analysis- by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 訂單完成後即時交付

價格

南美洲和中美洲肺癌篩檢市場預計將從2022年的3,916萬美元成長到2030年的6,895萬美元。預計2022年至2030年CAGR為7.3%。

肺癌篩檢測試的高成本推動了南美洲和中美洲肺癌篩檢市場。

隨著該地區醫療保健意識的不斷增強，該地區的肺癌篩檢提供者擁有充足的機會。其中包括與地區醫院和診所合作，透過這些醫院和診所可以提供方便的肺癌篩檢，並利用偏遠地區的遠距醫療。這種方法不僅能及早發現肺癌，還能改善病患的治療效果，填補該地區醫療保健的關鍵空白。透過滿足預防性護理不斷成長的需求，這些提供者可以在前景廣闊的市場中站穩腳跟，最終為改善整個地區的公共衛生和福祉做出貢獻。

南美洲和中美洲肺癌篩檢市場概述

南美洲和中美洲肺癌篩檢市場分為巴西、阿根廷以及南美洲和中美洲其他地區。該地區的成長歸因於多種因素，例如肺癌發病率的增加和人們對肺癌篩檢意識的增強。此外，政府對篩檢的支持不斷增加，導致市場進一步成長。

肺癌篩檢市場正受到癌症盛行率上升等因素的影響。例如，根據 Globocan 2020 報告，肺癌是巴西第二大流行癌症。巴西新增肺癌病例88492例。

肺癌篩檢被認為是全世界的照護標準。在巴西，其實施過程中的複雜因素與衛生系統的組織、CT 掃描和治療方法的獲取以及對該方法的文化接受程度有關，限制了這一進程。根據當地組織的說法，進行篩檢存在挑戰和障礙；然而，在所有情況下都有可能獲得令人滿意的結果。

據肺癌政策網路稱，在巴西，有必要採取協調一致的肺癌篩檢方法，因為全國各地的衛生援助分散，並導致了嚴重的健康不平等。最近，第二次巴西早期肺癌篩檢試驗 (BRELT2) 描述了 LDCT 篩檢的優點。儘管如此，在全國範圍內實施有組織的篩檢計畫之前，仍有許多障礙需要克服，包括公共和私人醫療保健機構之間使用篩檢設備的不平等。為了應對這項挑戰，作為 Propulmao 移動計畫的一部分，巴雷托斯（聖保羅）市衛生辦公室與當地癌症醫院合作，在社區提供行動 LDCT 篩檢和戒菸干預措施。

南美洲及中美洲肺癌篩檢市場收入及 2030 年預測（百萬美元）

南美洲和中美洲肺癌篩檢市場細分

南美洲和中美洲肺癌篩檢市場細分為癌症類型、技術、年齡層、最終用戶和國家。

根據癌症類型，南美洲和中美洲肺癌篩檢市場分為非小細胞肺癌（NSCLC）和小細胞肺癌。 2022 年，非小細胞肺癌 (NSCLC) 細分市場在南美洲和中美洲肺癌篩檢市場中佔據更大佔有率。

根據技術，南美洲和中美洲肺癌篩檢市場分為胸部 X 光、低劑量電腦斷層掃描 (LDCT)、液體活體組織切片等。 2022 年，胸部 X 光檢查在南美洲和中美洲肺癌篩檢市場中佔據最大佔有率。

根據年齡層，南美洲和中美洲肺癌篩檢市場分為50歲及以上和50歲以下。2022年，50歲及以上人口在南美洲和中美洲肺癌篩檢市場中佔據較大佔有率。

根據最終用戶，南美洲和中美洲肺癌篩檢市場分為醫院、診斷中心等。 2022 年，醫院細分市場在南美洲和中美洲肺癌篩檢市場中佔據最大佔有率。

根據國家/地區，南美洲和中美洲肺癌篩檢市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，巴西在南美洲和中美洲肺癌篩檢市場佔據主導地位。

西門子股份公司、荷蘭皇家飛利浦公司、佳能公司、美敦力公司和通用電氣醫療保健技術公司是南美洲和中美洲肺癌篩檢市場的一些領導公司。

目錄

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 南美洲和中美洲肺癌篩檢市場 - 按技術分類
    • 南美洲和中美洲肺癌篩檢市場 - 按癌症類型
    • 南美洲和中美洲肺癌篩檢市場 - 按年齡層
    • 南美洲和中美洲肺癌篩檢市場 - 按最終用戶分類
    • 南美洲和中美洲肺癌篩檢市場 - 按國家/地區

第 2 章：南美洲和中美洲肺癌篩檢市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲肺癌篩檢市場 - 市場格局

  • 概述
  • 南美洲和中美洲 PEST 分析
  • 專家意見

第 5 章：南美洲和中美洲肺癌篩檢市場 - 主要市場動態

  • 市場促進因素
    • 肺癌發生率上升
  • 市場限制
    • 肺癌篩檢測試成本高昂
  • 市場機會
    • 與地區醫院和診所的合作
  • 未來的趨勢
    • 使用尖端技術
  • 影響分析

第 6 章：肺癌篩檢市場 - 南美洲和中美洲分析

  • 南美洲和中美洲肺癌篩檢市場收入預測與分析

第 7 章：南美洲和中美洲肺癌篩檢市場 - 收入和 2028 年預測 - 按癌症類型

  • 概述
  • 2022 年和 2030 年南美洲和中美洲肺癌篩檢市場收入佔有率（按癌症類型分類）
  • 非小細胞肺癌 (NSCLC)
  • 小細胞肺癌

第 8 章：南美洲和中美洲肺癌篩檢市場分析 - 按技術

  • 概述
  • 低劑量電腦斷層掃描 (LDCT)
  • 胸部X光檢查
  • 液體活體組織切片
  • 其他

第 9 章：南美洲和中美洲肺癌篩檢市場分析 - 按年齡層

  • 概述
  • 及較舊的
  • 50以下

第 10 章：南美洲和中美洲肺癌篩檢市場分析 - 按最終用戶

  • 概述
  • 醫院
  • 診斷中心
  • 其他

第 11 章：南美洲和中美洲肺癌篩檢市場 - 收入和 2028 年預測 - 國家分析

  • 南美洲和中美洲肺癌篩檢市場概述

第 12 章：南美洲和中美洲肺癌篩檢市場-產業格局

  • 近期成長策略
    • 概述

第 13 章：公司簡介

  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG

第 14 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00029065

The South & Central America lung cancer screening market is expected to grow from US$ 39.16 million in 2022 to US$ 68.95 million by 2030. It is estimated to grow at a CAGR of 7.3% from 2022 to 2030.

High cost of lung cancer screening tests fuel South & Central America lung cancer screening market.

Amid growing healthcare awareness in the region, lung cancer screening providers in the region has ample opportunities. These include collaborating with regional hospitals and clinics through which they can offer accessible lung cancer screening and leveraging telemedicine for remote areas. This approach not only detects lung cancer early but also improves patient outcomes, filling a crucial gap in the region's healthcare. By aligning with the rising demand for preventive care, these providers can establish a foothold in a promising market, ultimately contributing to enhanced public health and well-being across the region.

South & Central America Lung Cancer Screening Market Overview

The South & Central America lung cancer screening market is segmented into the Brazil, Argentina, and the Rest of South & Central America. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing awareness of lung cancer screening among people. Also, rising government support for screening has led to the further growth of the market.

The lung cancer screening market is being influenced by factors such as the increasing prevalence of cancer. For instance, as per Globocan 2020 report, lung cancer is Brazil's second most prevalent cancer. There were 88492 new cases of lung cancer found in Brazil.

Lung cancer screening is believed to be the standard of care worldwide. In Brazil, complications in its implementation related to the organization of the health system, access to CT scans and treatment methods, and cultural acceptance of the method restrict the process. There are challenges and barriers in carrying out the screening according to the local organization; however, it was possible to obtain satisfactory results in all scenarios.

According to Lung Cancer Policy Network, In Brazil, a coordinated approach to lung cancer screening is necessary, as health assistance is fragmented across the country and has resulted in significant health inequalities. The advantages of LDCT screening were recently described in the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). Nevertheless, there are still many barriers to overcome before an organized screening program can be implemented nationwide, including inequitable access to screening equipment between public and private healthcare. To manage this challenge, as part of the Propulmao Mobile Project, the municipal health office in Barretos (Sao Paulo) collaborated with the local cancer hospital to deliver mobile LDCT screening and a smoking cessation intervention in the community.

South & Central America Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Lung Cancer Screening Market Segmentation

The South & Central America lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the South & Central America lung cancer screening market is segmented into non-small cell lung cancer (NSCLC), and small cell lung cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the South & Central America lung cancer screening market in 2022.

Based on technology, the South & Central America lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest X-ray segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on age group, the South & Central America lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the South & Central America lung cancer screening market in 2022.

Based on end user, the South & Central America lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the South & Central America lung cancer screening market in 2022.

Based on country, the South & Central America lung cancer screening market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lung cancer screening market in 2022.

Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, and GE HealthCare technologies Inc are some of the leading companies operating in the South & Central America lung cancer screening market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Lung Cancer Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Lung Cancer Screening Market - by Technology
    • 1.3.2 South & Central America Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 South & Central America Lung Cancer Screening Market - by Age Group
    • 1.3.4 South & Central America Lung Cancer Screening Market - by End User
    • 1.3.5 South & Central America Lung Cancer Screening Market - by Country

2. South & Central America Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Collaboration with Regional Hospitals and Clinics
  • 5.4 Future Trends
    • 5.4.1 Use of Cutting-Edge Technologies
  • 5.5 Impact Analysis

6. Lung Cancer Screening Market - South & Central America Analysis

  • 6.1 South & Central America Lung Cancer Screening Market Revenue Forecast and Analysis

7. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 South & Central America Lung Cancer Screening Market Overview
      • 11.1.1.1 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.3 Brazil: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 Brazil: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.5 Brazil: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.1.6 Brazil: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.3 Argentina: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Argentina: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.5 Argentina: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Argentina: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.3 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.5 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.3.6 Rest of South & Central America: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. South & Central America Lung Cancer Screening Market-Industry Landscape

  • 12.1 Recent Growth Strategies
    • 12.1.1 Overview

13. Company Profiles

  • 13.1 Nuance Communications Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 GE HealthCare
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Canon Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Koninklijke Philips NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Siemens AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

List of Tables

  • Table 1. Brazil South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 2. Brazil South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Argentina South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. Argentina South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Recent Growth Strategies in the South & Central America Lung Cancer Screening Market
  • Table 14. Glossary of Terms

List Of Figures

List of Figures

  • Figure 1. South & Central America Lung Cancer Screening Market Segmentation
  • Figure 2. South & Central America Lung Cancer Screening Market, by Country
  • Figure 3. South & Central America Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in South & Central America Lung Cancer Screening Market
  • Figure 5. South & Central America Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. South & Central America Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 9. South & Central America Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 10. South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 11. Non-Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. South & Central America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 14. Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Chest X-ray: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Liquid Biopsy: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: South & Central America Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. South & Central America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 19. & Older: South & Central America Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Mn)
  • Figure 26. South & Central America Lung Cancer Screening Market Revenue Share, by Key Country (2022 and 2030)
  • Figure 27. Brazil: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Argentina: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of South & Central America: South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)